Xcout Intel
Azitra Inc
Azitra, Inc. is a pharmaceutical company headquartered in Branford, Connecticut. The company focuses on developing novel treatments and maintains additional operational presence in Montreal.
Subscribe to see Azitra Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Azitra Inc at a glance
Azitra Inc is a therapeutics company headquartered in Branford, United States. It is publicly listed (AZTR) with a market capitalisation of $1.9M. Xcout tracks 8 named people at Azitra Inc, including Francisco D. Salva (President, Chief Executive Officer & Director).
Azitra Inc leadership
- Francisco D. SalvaPresident, Chief Executive Officer & Director
- Norman StaskeyChief Financial Officer & Treasurer
- Travis WhitfillCo-Founder, Chief Operating Officer, Secretary & Director
- Andrew McClaryDirector
- Barbara RyanDirector
- Francisco D. SalvaDirector
2 more named people on record for Azitra Inc, with roles, board committees and tenure — see the full roster →
Azitra Inc competitors
A few of Azitra Inc's closest competitors — see the full list of competitors and alternatives →
Searchlight Pharma Inc. is a specialty pharmaceutical company headquartered in Montreal, Quebec, committed to developing and commercializing innovative healthcare products.
Artizan Biosciences, Inc. is a biotechnology company headquartered in New Haven, Connecticut, focused on precision medicine and microbiome-driven therapeutics.
SemaThera Inc. is a biotechnology company headquartered in Montreal, Canada, focused on developing novel therapeutics and biologic treatments.
Thryv Therapeutics Inc., formerly known as LQT Therapeutics Inc., is a privately owned clinical-stage biotechnology company based in Montreal, Quebec, Canada. The company pioneers targeted therapeutic treatments addressing serious medical conditions. Operating out of its downtown Montreal headquarters, the firm manages dedicated research and development programs.
Azurity Pharmaceuticals is a U.S.-based specialty pharmaceutical company that develops and commercializes medicines for underserved patient populations, including treatments for rare diseases and complex conditions. It focuses on patient-friendly dosage forms and serves healthcare providers, patients, and caregivers, including pediatric and other populations with unmet medication needs.
Get Azitra Inc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Azitra Inc in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access